Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...
Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the ...
Company closed $22M financing to support randomized Phase 2b trial; IND cleared and study initiated; Interim results anticipated in late 2026; topline data expected in H2/2027 ...
With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...
Dr. Erika Hamilton spoke with CURE’s editor-in-chief, Dr. Joshua K. Sabari.
Abscopal effect refers to the shrinkage or regression of metastatic tumours that are distant from the irradiated field.
Belfast Live on MSN
'I was diagnosed with cancer just days after my daughter's first birthday'
A Northern Ireland mum has said being diagnosed with an incurable cancer just days after her daughter's first birthday "felt ...
A subgroup analysis of the phase 3 FOCUS study (NCT02678572) shows that the Melphalan/Hepatic Delivery System (HDS; HEPZATO ...
The cumulative incidence of CRLM has declined, with survival gains mainly in synchronous cases, highlighting the need for ...
Delcath Systems announces publication of subgroup analyses of phase 3 FOCUS study of Melphalan/Hepatic Delivery System in patients with unresectable metastatic uveal melanoma Queensbury, New York ...
2don MSN
Inspector General Report Finds Serious Failures Led to an Inmate Wasting Away From Treatable Cancer
A federal inmate died of treatable colon cancer after waiting six months for an urgent colonoscopy. Medical neglect like this ...
Florida Cancer Specialists & Research Institute, LLC (FCS) advances gastrointestinal cancer treatment through participation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback